Skip to Main Content
Back to News

New Analyst Forecast: $CTMX Given 'Overweight' Rating

None

We just received data on a new analyst forecast for $CTMX. Piper Sandler gave a rating of 'Overweight' for $CTMX.

$CTMX Analyst Ratings

Wall Street analysts have issued reports on $CTMX in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Piper Sandler issued a "Overweight" rating on 05/15/2025
  • H.C. Wainwright issued a "Buy" rating on 05/15/2025

To track analyst ratings and price targets for $CTMX, check out Quiver Quantitative's $CTMX forecast page.

$CTMX Insider Trading Activity

$CTMX insiders have traded $CTMX stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.

Here’s a breakdown of recent trading of $CTMX stock by insiders over the last 6 months:

  • SEAN A. MCCARTHY (CEO) sold 37,656 shares for an estimated $22,555
  • MARCIA BELVIN (SVP, Chief Scientific Officer) sold 19,512 shares for an estimated $11,687
  • LLOYD A ROWLAND (General Counsel) sold 10,203 shares for an estimated $6,111
  • CHRISTOPHER OGDEN (Chief Financial Officer) sold 8,551 shares for an estimated $5,122
  • YU-WAYE CHU (Chief Medical Officer) sold 4,025 shares for an estimated $2,410

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$CTMX Hedge Fund Activity

We have seen 26 institutional investors add shares of $CTMX stock to their portfolio, and 47 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your Google News feed.Google News Logo

Suggested Articles